The global immune thrombocytopenia treatment market is experiencing a period of significant expansion. This trend can be attributed to several factors, including an rising prevalence of immune thrombocytopenia worldwide and the launch of novel treatment approaches. Additionally, advancements in diagnostic methods are facilitating earlier diagnosis